2-Methyl-2H-indazole-3-carboxylic acid

HCID 7060537CAS 34252-44-3

Completing data — usually done within a minute

Substructure search Find similar structures

Basic information

Standard SMILES: Cn1nc2ccccc2c1C(=O)O
InChIKey: ABRISPFTOZIXMP-UHFFFAOYSA-N
Molecular formula: C9H8N2O2
Average molar mass: 176.175 g/mol
Monoisotopic mass: 176.0585775

Names & identifiers

Preferred name: 2-Methyl-2H-indazole-3-carboxylic acid
IUPAC: 2-Methyl-2H-indazole-3-carboxylic acid
English name: GRANISETRON-D3
Molecular formula: C9H8N2O2
Molecular weight: 176.17

Names & synonyms

Granisetron ImpurityClGranisetron EP impurity G3-Carboxy-2-methyl-2H-indazole2-Methylindazole-3-carboxylicAci2-Methylindazole-3-carboxylic acid2-Methyl-2H-indazole-3-carboxylic AGranisetron Hydrochloride Impurity G2-METHYL-2H-INDAZOLE-3-CARBOXYLIC ACID2H-Indazole-3-carboxylic acid,2-methyl-Granisetron Hydrochloride EP Impurity G

Database identifiers

CAS: 34252-44-3
PubChem CID: 7060537
DTXSID: DTXSID30427620
UNII: 7F74Q4NXW7
EC Number: 691-338-3

Properties

Physicochemical properties

Melting point: 217 · 217-219
Boiling point: 417.4 · 417.4±18.0 °C(Predicted)
Density: 1.35 · 1.35
storage temp.: Sealed in dry,Room Temperature
solubility: DMSO (Slightly), Methanol (Slightly)
form: Solid
pka: 3.02 · 3.02±0.10(Predicted)
color: White to Off-White
FDA UNII: 7 F74Q4NXW7 · 7F74Q4NXW7
Symbol(GHS): 7 · GHS07
Signal word: Warning
Hazard statements: 302 · H302-H315-H319-H332-H335
Precautionary statements: 261 · P261-P280-P305+P351+P338
Hazard Codes: Xn
Risk Statements: 22 · 22-36-36/37/38-20/21/22
Safety Statements: 26 · 26-36/37/39-22
RIDADR: 2811 · 2811
Hazard Note: Harmful
HS Code: 29339900 · 29339900

Safety & regulation

Safety data

ridadr: 2811
hs_code: 29339900
risk_code: 22-36-36/37/38-20/21/22
Signal word: Warning
Symbol(GHS): GHS07
hazard_code: Xn
hazard_note: Harmful
safety_code: 26-36/37/39-22
Hazard statements: H302-H315-H319-H332-H335
Precautionary statements: P261-P280-P305+P351+P338

Chemistry & industry

Applications

Uses2-Methyl-2H-indazole-3-carboxylic acid can be used as a reagent used to synthesize 5-HT2A and 5-HT3 receptor ligands for use in treating CNS-related disorders.